Artificial Intelligence: The next big thing in brand advertising

In this special guest feature, Bradley Merrill Thompson, a partner in the Washington DC office of law firm Epstein Becker; Green and Chairman of the Board of the firm's consulting affiliate EBG Advisors, starts a compelling and timely conversation on the FDA's approach to regulating machine learning.